Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia

There is conflicting information about the influence of body mass index (BMI) on the pharmacokinetics, toxicity, and outcome of chemotherapy. We compared pharmacokinetics, outcome, and toxicity data across 4 BMI groups (underweight, BMI ≤ 10th percentile; normal; at risk of overweight, BMI ≥ 85th an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hijiya, Nobuko, Panetta, John C., Zhou, Yinmei, Kyzer, Emily P., Howard, Scott C., Jeha, Sima, Razzouk, Bassem I., Ribeiro, Raul C., Rubnitz, Jeffrey E., Hudson, Melissa M., Sandlund, John T., Pui, Ching-Hon, Relling, Mary V.
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Hematology 2006
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895448/
https://ncbi.nlm.nih.gov/pubmed/16917005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-05-024414
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky